Ph.D., MBA, Founder and CEO, Dermala Inc.
Dr. Lada Rasochova is the founder and CEO of Dermala Inc., a human microbiome company developing treatments for chronic skin diseases and conditions. Dr. Rasochova has been involved in commercialization of biotech and pharma products for the past 20 years. She spent 15 years in industry where she held various leadership positions, including as the leader of Vaccine Technologies and director of new business development in Dowpharma, a biotech division of the Dow Chemical Company, Mycogen, a biotech startup (acquired by Dow Chemical), and the CEO of Jadus BioScience, an early stage diagnostic company. Dr. Rasochova is also the managing director of the Rady Venture Fund and serves as the founding executive director of the California Institute for Innovation and Development at UC San Diego, founding director of StartR and mystartupXX accelerators, and on boards of several companies, centers and institutes, including the UC San Diego Center for Drug Discovery Innovation and the Qualcomm Institute.
Presentation Title and Company Description
Microbial Profiling Showcase: The Human Microbiome, Metabolome, and Skin Health
Dermala is an early-stage consumer dermatology company utilizing the human skin and gut microbiome and metabolome to develop the next generation treatments for chronic skin diseases. We are developing personalized end-to-end solutions for our customers that deliver better outcomes without side effects.